Your browser doesn't support javascript.
loading
An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012-2016.
Tetteh, Ato Kwamena; Agyarko, Edward; Otchere, Joseph; Bimi, Langbong; Ayi, Irene.
Afiliación
  • Tetteh AK; Laboratory Department, Metropolitan Hospital, P.O. Box 174, Cape Coast, Ghana.
  • Agyarko E; Department of Community Medicine and Health, Anglican University College of Technology, P.O. Box 74, Nkoranza, Ghana.
  • Otchere J; Noguchi Memorial Institute for Medical Research, Department of Parasitology, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
  • Bimi L; Department of Animal Biology and Conservation Sciences, University of Ghana, Legon, Accra, Ghana.
  • Ayi I; Noguchi Memorial Institute for Medical Research, Department of Parasitology, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Tuberc Res Treat ; 2018: 4287842, 2018.
Article en En | MEDLINE | ID: mdl-29666702
We present, for the first time, an evaluation of treatment outcomes in a cohort at a TB referral centre in the Central Region of Ghana. Of the 213 clients placed on DOTS, 59.2% (126/213) were sputum smear-positive. An overall cure rate of 90.2% (51.6% cured + 37.6% completed) and a death rate of 8.5% (18/213) were estimated. Of the number of clients who died, 5.7% (12/213) were males (χ2 = 2.891, p = 0.699; LR = 3.004, p = 0.699). Deaths were only recorded among clients who were > 19 years old (χ2 = 40.319, p = 0.099; LR = 41.244, p = 0.083). Also, 0.9% (2/213) was lost to follow-up, while 1.4% (3/213) had treatment failure. In total, 13.6% (7.0%, 15/213 males, and 6.6%, 14/213 females) of clients who were placed on DOTS were HIV seropositive. Ages of 40-49 years had the highest number, 13/213 (6.1%), infected with HIV, though the difference among the remaining age groups was not statistically significant (χ2 = 9.621, p = 0.142). Furthermore, 7.0% (15/213) had TB/HIV coinfection. Out of them, 9 were cured and 5 died at home, while 1 had treatment failure. Tuberculosis/HIV infection prevention advocacy and interventions that address sociodemographic determinants of unfavourable treatment outcomes are urgently required to augment national efforts towards control.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Tuberc Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Ghana Pais de publicación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Tuberc Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Ghana Pais de publicación: Egipto